| Literature DB >> 28191316 |
Angela Colagross-Schouten1, Marie-Josee Lemoy1, Rebekah I Keesler1, Elaine Lissner2, Catherine A VandeVoort1,3.
Abstract
BACKGROUND: Options for male contraception are limited. The purpose of this study was to use a nonhuman primate model to evaluate Vasalgel™, a high molecular weight polymer being developed as a contraceptive device for men.Entities:
Keywords: Colony management; Contraception; Fertility; Hydrogel; Macaca mulatta; Primate; Sterilization; Styrene maleic acid polymer; Vas deferens; Vasalgel; Vasectomy
Year: 2017 PMID: 28191316 PMCID: PMC5294830 DOI: 10.1186/s12610-017-0048-9
Source DB: PubMed Journal: Basic Clin Androl ISSN: 2051-4190
Animal information on date of Vasalgel administration, age at time of Vasalgel administration, time males spent with intact female(s) after post-operative recovery through June 1, 2016, and previous conception number
| Animal ID | Treatment date | Age at surgery | Dates housed with intact females | Total time with female | Previous conception number |
|---|---|---|---|---|---|
| 1a | 7/9/14 | 12 y 1 m | 7/24/14 –3/2/2016 | 1 y 8 m | 18 |
| 2a | 7/9/14 | 8 y 3 m | 8/4 – 12/21/14, 12/30/14–1/20/15, 2/2–11/3/15, 11/23/15– 3/2/2016, 3/10/16–5/23/16 | 1 y 8 m | 5 |
| 3a | 7/9/14 | 6 y 2 m | 8/1/14 – 11/23/15, 12/15/15–2/24/16, 2/25– 3/2/2016 | 1 y 6 m 7 d | 0 |
| 4a | 7/9/14 | 5 y 9 m | 7/18/14–1/2/15, 1/22–3/4/15, 3/10/15–4/17/15 | 8 m 2 d | 1 |
| 5a | 7/10/14 | 5 y 9 m | 7/18–11/18/14, 11/26–12/10/14, 12/19/14–1/20/15, 1/23–3/4/15, 3/10/15–3/20/16 | 18 m 15 d | 0 |
| 6a | 7/10/14 | 8 y 2 m | 7/15/14– 7/27/16 | 2 y 12 d | 6 |
| 7a | 7/10/14 | 16 y 3 m | 7/15/14– 7/27/16 | 2 y 12 d | 4 |
| 8 | 7/10/14 | 6 y 2 m | 7/15/14–12/28/15 | 1 y 5 m 13 d | 1 |
| 9 | 7/10/14 | 5 y 2 m | 7/15/14–8/15/15, 8/25/15–5/2/2016 | 1 y 9 m 7 d | 3 |
| 10 | 8/13/14 | 6 y 4 m | 8/22–10/5/14, 10/14/-12/1/14, 12/4/14–1/12/15, 1/13/15–5/11/15 | 8 m 6 d | 7 |
| 11 | 8/13/14 | 6 y 5 m | 8/22/14–5/11/15 | 8 m 19 d | 2 |
| 12 | 8/13/14 | 6 y 4 m | 8/22/14–5/11/15 | 8 m 19 d | 5 |
| 13 | 8/21/14 | 6 y 1 m | 8/28/14–8/26/15 | 11 m 29 d | 0 |
| 14 | 8/21/14 | 4 y 4 m | 8/28–10/26/14, 10/28–12/4/14, 12/16/14–2/19/15, 2/27–4/17/15 | 6 m 28 d | 0 |
| 15 | 8/29/14 | 4 y 4 m | 9/9–12/2/14, 12/23/14–2/8/15, 2/18–4/17/15 | 5 m 14 d | 0 |
| 16 | 8/29/14 | 6 y 1 m | 9/9/14–4/17/15 | 7 m 8 d | 0 |
Y year, m month, d day.
aIndicates males housed with females for two breeding seasons
Fig. 1Animal 2: Abundant collagenous stroma surrounded by pyogranulomatous inflammation (orange arrow), and fibrin (black star). The clear spaces represent areas that contained sutures (asterisk). In the center of the image, is a small globule of basophilic to amphophilic material (black arrow, presumed Vasalgel). H&E, 40x
Fig. 2Animal 2: Same section as Fig. 1. In the center of the image, is a small, irregular globule of basophilic to amphophilic material (black arrow, presumed Vasalgel). There is no associated inflammation. Clear areas of sutures are noted (asterisk). H&E, 100x
Complications encountered in aged-matched control rhesus macaques undergoing traditional vasectomy at the CNPRC
| Animal ID | Age at surgery | Complication |
|---|---|---|
| 1 | 12 y 4 m | None |
| 2 | 8 y 3 m | None |
| 3 | 6 y 2 m | None |
| 4 | 5 y 9 m | Left sperm granuloma |
| 5 | 5 y 8 m | None |
| 6 | 8 y 2 m | Mild left testicular atrophy |
| 7 | 16 y 3 m | Left sperm granuloma |
| 8 | 6 y 2 m | Right sperm granuloma |
| 9 | 5 y 2 m | Left sperm granuloma |
| 10 | 6 y 4 m | None |
| 11 | 6 y 4 m | Mild suture reaction |
| 12 | 6 y 4 m | None |
| 13 | 6y 2 m | None |
| 14 | 4 y 4 m | None |
| 15 | 4 y 4 m | None |
| 16 | 6 y 2 m | Left side sperm granuloma |
Y year, m month